Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

Alli Orlistat Liver Damage Legal News Articles & Interviews

Glaxo Looking to Advance Rest of OTC Asset Sales As Alli Side Effects Remain

Glaxo Looking to Advance Rest of OTC Asset Sales As Alli Side Effects Remain February 1, 2012. By Charles Benson.
London, England GlaxoSmithKline Plc is trying to sell its remaining over-the-counter medicine brands as quickly as possible, due to the ongoing issues with Alli side effects and other medications, according to Bloomberg.
Read [ Glaxo Looking to Advance Rest of OTC Asset Sales As Alli Side Effects Remain ]

European Medicines Agency Concerned Over Orlistat Liver Damage; FDA Falls Silent

European Medicines Agency Concerned Over Orlistat Liver Damage; FDA Falls Silent January 4, 2012. By Gordon Gibb.
Washington, DC It's been about 18 months now since the US Food and Drug Administration (FDA) articulated its latest cautionary initiative regarding Orlistat, the weight-loss drug that is sourced by prescription but is also available in a different strength over the counter (OTC) as Alli. That's when the FDA approved new safety labeling for both Alli and its big brother Xenical that stemmed from a review of the drug in light of concern over severe liver injury.
Read [ European Medicines Agency Concerned Over Orlistat Liver Damage; FDA Falls Silent ]

Are Orlistat Benefits Worth the Alli Side Effects?

Are Orlistat Benefits Worth the Alli Side Effects? December 5, 2011. By Heidi Turner.
Helena, MT When it comes to losing weight, many people are willing to risk minor Alli side effects so they can achieve the results they want. But are the benefits worth the reported Alli side effects? Public Citizen, a public advocacy organization, says the risks of drugs that contain orlistat (the generic version of Alli) are far too high, and the benefits are too low. The organization called for a ban of Alli because of the risk of orlistat side effects.
Read [ Are Orlistat Benefits Worth the Alli Side Effects? ]

Public Citizen Calls for Ban on Alli

Public Citizen Calls for Ban on Alli November 19, 2011. By Heidi Turner.
Washington, DC For patients desperate to lose weight, the risk of Alli side effects may not be all that much of a concern. After all, the risks associated with being overweight include diabetes, heart disease and other serious health problems. But for some people, the risk of side effects associated with Alli, known generically as orlistat, are simply too high. These orlistat side effects have resulted in at least one organization—Public Citizen—calling for a ban on the medication.
Read [ Public Citizen Calls for Ban on Alli ]

Weight Loss Drug Included in Programs despite Alli Side Effects

Weight Loss Drug Included in Programs despite Alli Side Effects November 2, 2011. By Charles Benson.
Portland, OR A combination of weight loss programs that focus on behavioral changes and medications have been found by a review to help people shed pounds, despite the Alli side effects, according to HealthDay News.
Read [ Weight Loss Drug Included in Programs despite Alli Side Effects ]

EMA to Examine Alli Side Effects

EMA to Examine Alli Side Effects October 21, 2011. By Heidi Turner.
Washington, DC The European Medicines Agency (EMA) has announced it is reviewing information regarding Alli side effects following reports of Alli liver damage. The agency is concerned about serious cases of orlistat side effects, which reportedly include severe liver injury. The US Food and Drug Administration has also received reports about serious Alli side effects.
Read [ EMA to Examine Alli Side Effects ]

Alli-oops: FDA vs. GSK on Orlistat Liver Damage

Alli-oops: FDA vs. GSK on Orlistat Liver Damage September 15, 2009. By Gordon Gibb.
Washington, DC Just a few weeks after the US Food and Drug Administration (FDA) revealed its safety review of diet drug Alli due to reports of orlistat side effects and orlistat liver damage, alli manufacturer GlaxoSmithKline (GSK) has launched a defense of its weight loss drug.
Read [ Alli-oops: FDA vs. GSK on Orlistat Liver Damage ]

Is Alli the Next Fen-Phen?

Is Alli the Next Fen-Phen? September 4, 2009. By Jane Mundy.
Washington, DC Little more than a decade ago, thousands and thousands of consumers suffered severe side effects from Fen-phen, and even now, many people continue to be diagnosed with primary pulmonary hypertension, a life-threatening illness. Have Alli users forgotten the dangers of weight-loss drugs such as over-the-counter Alli or the prescription product, Xenical?
Read [ Is Alli the Next Fen-Phen? ]


Request Legal Help Now! - Free